Newsroom

latest news from ose
and across our portfolio

Featured News

Oxford Spinout Oxford Semantic Technologies acquired by Samsung Electronics
Oxford Spinout Oxford Semantic Technologies acquired by Samsung ElectronicsArticle links to www.oxionics.com
Oxford Ionics breaks global quantum performance records
Oxford Ionics breaks global quantum performance records
Times Commentary: Science innovation must be at the heart of government action
Times Commentary: Science innovation must be at the heart of government actionArticle links to www.beacontx.com
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene TherapiesArticle links to www.prnewswire.com
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptography
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptographyArticle links to www.globenewswire.com
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raises
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raisesArticle links to www.businesswire.com
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group

All News

Portfolio NewsOxford NanoimagingONI and Massive Photonics Announce a Successful Collaboration Bringing DNA-PAINT Technology to the NanoimagerPortfolio NewsOxford NanoimagingRevolutionizing EV Research: Introducing ONI’s Next-Generation End-to-End SolutionPortfolio NewsOxford NanoimagingONI Welcomes Dr. Alex Aravanis, MD, PhD, as Newest Board MemberPortfolio NewsOxford NanoimagingONI Appoints Paul Scagnetti as CEO to Implement Next Chapter of GrowthPortfolio NewsOxford NanoimagingOxford Nanoimaging closes $75 million Series B led by ARCH Venture Partners and Casdin CapitalPortfolio NewsOxford NanoimagingOxford Nanoimaging among the +20 organisations brought together by the Cell and Gene Therapy Catapult to accelerate technology development in cell and gene therapy manufacturingPortfolio NewsOxford NanoimagingOxford Nanoimaging welcomes Dr Tyler Ralston as Chief Technology Officer